Latest commentary on splicing vulnerability in spliceosome-mutated blood malignancies published in Trends in Biochemical Sciences. IMol Group leader Dr. Maciej Cieśla and Dr. Cristian Bellodi from Lund University
Stem Cell Center discuss new findings from the Abdel-Wahab and Bradley labs published in Molecular Cell.
Link to the commentary: https://authors.elsevier.com/.../S0968-0004(24)00111-7
Link to the original paper: https://www.sciencedirect.com/.../pii/S1097276524002843...
Comments